KERENDIA

Bayer Inc🇨🇦 Health Canada

Approval Id: 90cd67d9343384eb
Drug Approval Canada Name: KERENDIA
Product Name: KERENDIA
Status: Marketed
Status Date: 2022-11-22
Original Market Date: 2022-11-22
Din: 02531925
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:32.20
Atc Original: C03DA05 FINERENONE
Atc Name: c 03 da 05
Aig Number: 0164141002
Company Name: Bayer Inc
Company Address: 2920 Matheson Blvd East, Mississauga, Ontario, Canada, L4W 5R6

FINERENONE

20 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

90cd67d9343384eb

Type

Standard